Bausch Health Companies Inc. Stock Analysis & AI Score
Bausch Health Companies Inc. (BHC) has an ST Score of 65.2 (B), driven by its Sentiment (A+) and held back by its Financial Strength (C). Analysts rate it Buy with a $9.83 price target (+74.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Bausch Health Companies Inc. (BHC) has an ST Score of 65.2 (B), driven by its Sentiment (A+) and held back by its Financial Strength (C). Analysts rate it Buy with a $9.83 price target (+74.0% upside).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthC
All factor grades
- SentimentA+
- ProfitabilityA-
- ForecastB+
- ValuationB
- MomentumB
- GrowthC+
- Financial StrengthC
- Piotroski6/9
Contact
BHC stock: frequently asked questions
What is BHC's ST Score?
Bausch Health Companies Inc. (BHC) has an ST Score of 65.2 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BHC a buy, hold, or sell?
Analysts rate BHC a Buy, with a price target of $9.83 (+74.0% vs the current price). Our ST Score grades it B (65.2/100). The ST Score is a data-driven signal, not a recommendation.
What are BHC's factor grades?
Valuation B, Profitability A-, Financial Strength C, Momentum B, Growth C+, Forecast B+, Sentiment A+.
What is BHC's valuation grade?
Bausch Health Companies Inc. (BHC) earns a valuation grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BHC's growth grade?
Bausch Health Companies Inc. (BHC) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BHC's profitability grade?
Bausch Health Companies Inc. (BHC) earns a profitability grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BHC's financial strength grade?
Bausch Health Companies Inc. (BHC) earns a financial strength grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BHC?
The average analyst price target for Bausch Health Companies Inc. (BHC) is $9.83 from 38 analysts, which is +74.0% versus the recent price of $5.65.
What is BHC's Piotroski score?
Bausch Health Companies Inc. (BHC) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.